We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.1B
AUM Growth
-$4.09B
Cap. Flow
-$2.77B
Cap. Flow %
-10.63%
Top 10 Hldgs %
22.95%
Holding
1,846
New
56
Increased
388
Reduced
1,301
Closed
96

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$366M
2
MSFT icon
Microsoft
MSFT
+$279M
3
AMZN icon
Amazon
AMZN
+$213M
4
TSLA icon
Tesla
TSLA
+$109M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.74%
2 Consumer Staples 11.79%
3 Consumer Discretionary 11.57%
4 Industrials 10.74%
5 Healthcare 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDN icon
876
Radian Group
RDN
$5.14B
$554K ﹤0.01%
28,721
-2,986
-9% -$63.6K
DTM icon
877
DT Midstream
DTM
$14.9B
$551K ﹤0.01%
10,614
-245
-2% -$13.2K
GH icon
878
Guardant Health
GH
$19.5B
$551K ﹤0.01%
10,224
+617
+6% +$31.7K
INSP icon
879
Inspire Medical Systems
INSP
$1.42B
$551K ﹤0.01%
3,112
+55
+2% +$11.1K
SFBS
880
ServisFirst Bancshares
SFBS
$4.79B
$549K ﹤0.01%
6,862
-176
-3% -$14.8K
WK icon
881
Workiva
WK
$2.94B
$549K ﹤0.01%
7,063
-438
-6% -$29.9K
ACM icon
882
Aecom
ACM
$9.07B
$548K ﹤0.01%
8,022
-169
-2% -$12K
CIVI
883
DELISTED
Civitas Resources
CIVI
$548K ﹤0.01%
9,542
-816
-8% -$48K
ONC
884
BeOne Medicines Ltd
ONC
$33.8B
$548K ﹤0.01%
4,067
+237
+6% +$40.7K
AGNC icon
885
AGNC Investment
AGNC
$12.3B
$535K ﹤0.01%
63,473
-3,575
-5% -$42K
PCRX icon
886
Pacira BioSciences
PCRX
$1.02B
$534K ﹤0.01%
10,054
+164
+2% +$9.12K
BLDR icon
887
Builders FirstSource
BLDR
$7.84B
$528K ﹤0.01%
8,959
-1,052
-11% -$65.8K
HP icon
888
Helmerich & Payne
HP
$3.53B
$524K ﹤0.01%
14,203
-368
-3% -$15.5K
AMG icon
889
Affiliated Managers Group
AMG
$9.46B
$521K ﹤0.01%
4,657
-207
-4% -$26K
NET icon
890
Cloudflare
NET
$93B
$521K ﹤0.01%
9,427
-1,678
-15% -$99.7K
VIAV icon
891
Viavi Solutions
VIAV
$9.75B
$518K ﹤0.01%
39,700
-2,258
-5% -$32.2K
SCI icon
892
Service Corp International
SCI
$11.4B
$516K ﹤0.01%
8,940
-163
-2% -$10.7K
CRSP icon
893
CRISPR Therapeutics
CRSP
$4.58B
$510K ﹤0.01%
7,804
+610
+8% +$44.2K
ACHC icon
894
Acadia Healthcare
ACHC
$3.17B
$501K ﹤0.01%
6,409
-49
-0.8% -$3.92K
EXE
895
Expand Energy Corp
EXE
$21.9B
$501K ﹤0.01%
+5,323
New +$500K
INSM icon
896
Insmed
INSM
$23.2B
$500K ﹤0.01%
23,239
+534
+2% +$12.8K
HIW icon
897
Highwoods Properties
HIW
$3.71B
$499K ﹤0.01%
18,519
-731
-4% -$23.6K
SFM icon
898
Sprouts Farmers Market
SFM
$7.04B
$498K ﹤0.01%
17,954
-661
-4% -$18.8K
SNAP icon
899
Snap
SNAP
$7.32B
$498K ﹤0.01%
50,720
-6,509
-11% -$75.7K
FNB icon
900
FNB Corp
FNB
$6.78B
$495K ﹤0.01%
42,720
+285
+0.7% +$3.38K

Similar funds

ProShare Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, ProShare Advisors held 1,846 positions worth $26.1B, down 14% from $30.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

ProShare Advisors withdrew a net $2.77B in Q3 2022, closing 96 positions and reducing 1,301 holdings. Its most notable exit was Neenah, Inc. Common Stock, an estimated $7.52M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, ProShare Advisors opened a new position in Xometry worth $7.31M.

  • ProShare Advisors's largest Q3 2022 buy was Xometry: 128,758 shares worth $7.31M.
  • ProShare Advisors added most to Target in Q3 2022, an estimated $49.4M increase.
  • ProShare Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $366M.
  • ProShare Advisors fully exited Neenah, Inc. Common Stock in Q3 2022, selling an estimated $7.52M.
  • ProShare Advisors's ten largest holdings make up 23% of its $26.1B portfolio in Q3 2022.
  • ProShare Advisors opened 56 new positions and closed 96 in Q3 2022.
  • ProShare Advisors's portfolio value fell 14% quarter-over-quarter to $26.1B.

Based on ProShare Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.